Send feedback

MERTK p.Arg20Ser

c.60A>T · rs35898499 · VCV95372

Conflicting classifications of pathogenicity Conflicting submitters
Classification
Conflicting classifications of pathogenicity
ClinVar
Review
Conflicting submitters ★☆☆☆
ClinVar · 7 submitters
AlphaMissense
likely benign
0.1178 · ACMG-weighted
gnomAD v4.1
Common
common (popmax 7.52%, mid) — too common for a highly-penetrant pathogenic allele
Missense predictors
0/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
2
retinitis pigmentosa

Computational evidence

Protein change
AlphaMissense0.1178likely benign
REVEL0.076moderately benign-leaning
SaProtLLR -5.35tolerated
⇒ AlphaMissense, REVEL and SaProt all call this tolerated.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 2GERP -2, phastCons 0.98
Regional constrainto/e 0.90unconstrained · MANE · 130 kb · p 0.00043 · regional, not allelic
Overall
CADD14.73PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 7.52% Middle Eastern · 448/5,958 alleles
Filtering AF 6.94% ClinGen BA1/BS1 input FAF95, joint · FAF99 6.72%
Overall 4.06% 64,669/1,591,892 alleles · common
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 12.2% 8
Middle Easterngrpmax 7.52% 13
Amishnot grpmax-eligible 5.59% 18
Remaining individualsnot grpmax-eligible 4.52% 22
European (non-Finnish) 4.5% 22
Finnishnot grpmax-eligible 2.88% 35
Admixed American 2.65% 38
South Asian 1.47% 68
African / African-American 0.773% 129
East Asian 0.0137% 7,311

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
MERTK
Protein
p.Arg20Ser
Coding
c.60A>T
MANE Select
NM_006343
dbSNP
rs35898499
Type
single nucleotide variant
Location
chr2:111898795 (GRCh38)
Gene constraint
LOEUF 0.787 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 72.78 · 42 PDB
Residue 20
a UniProt-annotated variant site (in)
Full MERTK gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

retinitis pigmentosa — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

Also linked: retinitis pigmentosa 38

For Retinitis pigmentosa (Orphanet):

Inheritance
Autosomal dominant, Autosomal recessive, Mitochondrial inheritance
Onset
Adolescent, Adult, Childhood
Prevalence
1-5 / 10 000 (Europe)

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/mertk-p-arg20ser (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown